The Gross Law Firm
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of PRVB, OCGN and DKNG
NEW YORK, NY / ACCESSWIRE / July 19, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.
Provention Bio, Inc. (NASDAQ:PRVB)
Investors Affected: November 2, 2020 - April 8, 2021
A class action has commenced on behalf of certain shareholders in Provention Bio, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the teplizumab Biologics License Application ("BLA") was deficient in its submitted form and would require additional data to secure U.S. Food and Drug Administration approval; (ii) accordingly, the teplizumab BLA lacked the evidentiary support the Company had led investors to believe it possessed; (iii) the Company had thus overstated the teplizumab BLA's approval prospects and hence the commercialization timeline for teplizumab; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.
Shareholders may find more information at https://securitiesclasslaw.com/securities/provention-bio-inc-loss-submission-form/?id=17782&from=1
Ocugen, Inc. (NASDAQ:OCGN)
Investors Affected: February 2, 2021 - June 10, 2021
A class action has commenced on behalf of certain shareholders in Ocugen, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the information submitted to the U.S. Food and Drug Administration ("FDA") was insufficient to support an Emergency Use Authorization ("EUA"), (ii) Ocugen would not file an EUA with the FDA, (iii) as a result of the foregoing, the Company's financial statements, as well as Defendants' statements about Ocugen's business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.
Shareholders may find more information at https://securitiesclasslaw.com/securities/ocugen-inc-loss-submission-form/?id=17782&from=1
DraftKings Inc. f/k/a Diamond Eagle Acquisition Corp. (NASDAQ:DKNG)
Investors Affected: December 23, 2019 - June 15, 2021
A class action has commenced on behalf of certain shareholders in DraftKings Inc f/k/a Diamond Eagle Acquisition Corp. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) SBTech Global Limited ("SBTech"), a company acquired by DraftKings, had a history of unlawful operations; (ii) accordingly, DraftKings' merger with SBTech exposed the Company to dealings in black-market gaming; (iii) the foregoing increased the Company's regulatory and criminal risks with respect to these transactions; (iv) as a result of all the foregoing, the Company's revenues were, in part, derived from unlawful conduct and thus unsustainable; (v) accordingly, the benefits of the Business Combination were overstated; and (vi) as a result, the Company's public statements were materially false and misleading at all relevant times.
Shareholders may find more information at https://securitiesclasslaw.com/securities/draftkings-inc-f-k-a-diamond-eagle-acquisition-corp-loss-submission-form/?id=17782&from=1To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Phone: (212) 537-9430
Fax: (833) 862-7770
SOURCE: The Gross Law Firm
View source version on accesswire.com:
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
Planet 13 Holdings6.8.2021 00:12:19 CEST | Press release
Planet 13 Illinois Wins Chicago License
Monarch Mining Corporation5.8.2021 22:46:35 CEST | Press release
Monarch Mining Corporation Announces the Closing of the $11.25 Million Transaction With Gold Royalty Corp.
Adcore Inc.5.8.2021 21:01:58 CEST | Press release
Adcore Announces Conference Call to Discuss Second Quarter 2021 Financial Results
Linkfire5.8.2021 19:52:26 CEST | Press release
Linkfire Expands Agreement with Global Tech Company
ReelTime Rentals Inc5.8.2021 15:19:06 CEST | Press release
OTC Markets Upgrades RLTR to Highest Designation of Providing Current Information Meeting Upcoming Amended SEC Rule15c2-11 Guidelines
New Jersey Mining Company5.8.2021 15:02:35 CEST | Press release
New Jersey Mining Co. Receives Trademark Approvals and Advances Apparel Brand with Release of its "Flynn" Skeleton Series and "Toughest Hat in Your Closet" Campaign
Engage People5.8.2021 15:02:15 CEST | Press release
Engage People Named in 'Now Tech: Promotions and Offer Management Providers, Q3 2021' Report by Independent Research Firm
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom